منابع مشابه
Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition.
A 46-year-old patient underwent implantation of a bioresorbable vascular scaffold (BVS) (Absorb 3.5 28 mm, Abbott Vascular, Abbott Park, Illinois) in April 2013 for a de-novo stenosis of the right coronary artery (Figures 1A to 1B). A total of 6 months after implantation, a follow-up angiography including optical coherence tomography (OCT) was performed, showing a partial malapposition of the s...
متن کاملVery late bioresorbable scaffold thrombosis after discontinuation of dual antiplatelet therapy
Inflammation induced by pathogens or of autoimmune origin is particularly harmful to terminally differentiated organs with poor regenerative capacity, such as the heart and brain. Chronic inflammation is thought to impair heart failure, neurodegenerative diseases, and metabolic syndrome. Interestingly, increased resting heart rate has been linked to cognitivedecline after ischaemic stroke. This...
متن کاملVery late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . doi:10.1093/eurheartj/ehu419 Online publish-ahead-o...
متن کاملTriple, simultaneous, very late coronary stent thrombosis.
Coronary artery stent thrombosis is an uncommon but potentially catastrophic complication. The risk of very late stent thrombosis (VLST) raises important safety issues regarding the first generation of drug-eluting stents (DES). Although several complex mechanisms for VLST have been suggested and various predictors have been described, its pathophysiology is not completely understood and it is ...
متن کاملVery late transcatheter heart valve thrombosis
We describe a case of very late transcatheter heart valve (THV) thrombosis of a first-generation SAPIEN prosthesis (Edwards Lifesciences, Irvine, CA) implanted in a 64-year-old woman with severe symptomatic aortic stenosis. More than 54 mo after implantation, she presented with severe symptomatic prosthesis dysfunction (stenosis) which was successfully treated with oral anticoagulation. To our ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2015
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2015.08.853